CEO and co-founder of BoostSuite
VP of Research and Special Initiatives, Google
Founder and CEO, Lighter Capital
CEO and Co-Founder, Tamr
Co-Founder and CEO, DNAnexus
CEO and Fund Manager, Renaissance Venture Capital Fund
VP of Research & Policy, Ewing Marion Kauffman Foundation
February 20, 2018 ·
Sponsored · Whitepaper
Moreover, more than half of Fortune 500 pharmaceutical and medica
New stereolithography technology makes 3D printing of models, molds, and parts more accessible and affordable than ever.
The pressure has never been greater for life science organizations to shorten the development cycle for new drugs and devices.
The state’s programs for entrepreneurs made a record-setting impact in 2016.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.